Novan, Inc. filed a notice for the selection of Successful Bidder in the US Bankruptcy Court for the sale of certain assets on September 1, 2023. As a result of the auction conducted on August 31, 2023, and Ligand Pharmaceuticals has been selected as the winning bidder for the sale of debtor?s certain assets. The debtor?s assets include R&D Assets and certain Commercial Assets.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0008 USD | 0.00% | 0.00% | +60.00% |
Jan. 17 | First Amended Combined Liquidation Plan and Disclosure Statement Filed by NVN Liquidation, Inc. | CI |
2023 | Modified Disclosure Statement Approved on Interim Basis for NVN Liquidation, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
+60.00% | 22.41K | |
+137.37% | 5.68B | |
+1.89% | 1.01B | |
+2.19% | 982M | |
+41.91% | 872M | |
+25.27% | 819M | |
+1.68% | 663M | |
+0.54% | 610M | |
-.--% | 600M | |
+21.31% | 552M |
- Stock Market
- Equities
- NOVN.Q Stock
- News NVN Liquidation, Inc.
- Notice of selection of Successful Bidder Filed by Novan, Inc.